切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2024, Vol. 18 ›› Issue (01) : 1 -5. doi: 10.11817/j.issn.1673-9248.2024.01.001

述评

2023年中国卒中临床转化研究重要进展巡礼
曹雯1, 张淦1, 黄昕1, 付佳钰1, 傅瑜1,(), 樊东升1,()   
  1. 1. 100191 北京大学第三医院神经内科
  • 收稿日期:2024-01-15 出版日期:2024-02-01
  • 通信作者: 傅瑜, 樊东升
  • 基金资助:
    北京大学第三医院临床队列建设项目(BYSYDL2023014); 2023年北京市重大疑难疾病中西医协同攻关项目示范项目(2023BJSZDYNJBXTGG-015)

Review of important progress in clinical translational research on stroke in China in 2023

Wen Cao, Gan Zhang, Yu Fu   

  • Received:2024-01-15 Published:2024-02-01
引用本文:

曹雯, 张淦, 黄昕, 付佳钰, 傅瑜, 樊东升. 2023年中国卒中临床转化研究重要进展巡礼[J]. 中华脑血管病杂志(电子版), 2024, 18(01): 1-5.

Wen Cao, Gan Zhang, Yu Fu. Review of important progress in clinical translational research on stroke in China in 2023[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2024, 18(01): 1-5.

卒中是一种严重危害人类健康的慢性非传染性疾病。自2005年以来,每年中国的卒中死亡人数约占全球卒中死亡总数的1/3,是中国人群的主要死亡原因。中国人终身卒中风险为39.3%,是世界其他地区平均风险的1.6倍,在195个国家中居首位。根据2019年全球疾病负担报告,与1990年相比,2019年中国人群卒中的发病率、患病率、死亡率和残疾调整生命年(disability-adjusted life year,DALY)分别增加了86.02%、105.99%、32.29%和13.73%,因此,卒中受到越来越多的重视。在过去的2023年,我国学者在卒中领域取得了一系列重大突破,本文旨在对2023年中国卒中临床转化研究的主要研究成果进行总结。

1
Global burden of 369 diseases and injuries in 204 countries and territories, 1990—2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet, 2020, 396(10258): 1204-1222.
2
Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2019, 394(10204): 1145-1158.
3
Feigin VL, Nguyen G, Cercy K, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016 [J]. N Engl J Med, 2018, 379(25): 2429-2437.
4
Wang Y, Liang J, Fang Y, et al. Burden of common neurologic diseases in Asian Countries, 1990—2019: an analysis for the Global Burden of Disease Study 2019 [J]. Neurology, 2023, 100(21): e2141-e2154.
5
Yao M, Ren Y, Jia Y, et al. Projected burden of stroke in China through 2050 [J]. Chin Med J (Engl), 2023, 136(13): 1598-1605.
6
Fan J, Li X, Yu X, et al. Global burden, risk factor analysis, and prediction study of ischemic stroke, 1990-2030 [J]. Neurology, 2023, 101(2): e137-e150.
7
Sang S, Chu C, Zhang T, et al. The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019 [J]. Ecotoxicol Environ Saf, 2022, 238: 113588.
8
Zheng M, Zheng S. Endometriosis increases the risk of stroke: a mendelian randomization study [J]. Stroke, 2023, 54(2): e30-e33.
9
Duan Y, Zhao D, Sun J, et al. Lipoprotein(a) is associated with the progression and vulnerability of new-onset carotid atherosclerotic plaque [J]. Stroke, 2023, 54(5): 1312-1319.
10
Wang Y, Li S, Pan Y, et al. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial [J]. Lancet, 2023, 401(10377): 645-654.
11
Chen HS, Cui Y, Zhou ZH, et al. Effect of argatroban plus intravenous alteplase vs intravenous alteplase alone on neurologic function in patients with acute ischemic stroke: the ARAIS randomized clinical trial [J]. JAMA, 2023, 329(8): 640-650.
12
Majoie CB, Cavalcante F, Gralla J, et al. Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials [J]. Lancet, 2023, 402(10406): 965-974.
13
Chen HS, Cui Y, Zhou ZH, et al. Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial [J]. JAMA, 2023, 329(24): 2135-2144.
14
Liu H, Jing J, Wang A, et al. Genotype-guided dual antiplatelet therapy in minor stroke or transient ischemic attack with a single small subcortical infarction [J]. Neurology, 2023, 100(16): e1643-e1654.
15
Sang H, Xie D, Tian Y, et al. Association of tirofiban with functional outcomes after thrombectomy in acute ischemic stroke due to intracranial atherosclerotic disease [J]. Neurology, 2023, 100(19): e1996-e2006.
16
Zi W, Song J, Kong W, et al. Tirofiban for stroke without large or medium-sized vessel occlusion [J]. N Engl J Med, 2023, 388(22): 2025-2036.
17
Pan Y, Meng X, Yuan B, et al. Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial [J]. Lancet Neurol, 2023, 22(6): 485-493.
18
Wang A, Jia B, Zhang X, et al. Efficacy and safety of butylphthalide in patients with acute ischemic stroke: a randomized clinical trial [J]. JAMA Neurol, 2023, 80(8): 851-859.
19
Xu Y, Liu C, Li W, et al. Efficacy and safety of early anticoagulation after endovascular treatment in patients with atrial fibrillation [J]. Stroke Vasc Neurol, 2023, 8(5): 405-412.
20
Ip Y, Lau KK, Ko H, et al. Association of alternative anticoagulation strategies and outcomes in patients with ischemic stroke while taking a direct oral anticoagulant [J]. Neurology, 2023, 101(4): e358-e369.
21
Huo X, Ma G, Tong X, et al. Trial of endovascular therapy for acute ischemic stroke with large infarct [J]. N Engl J Med, 2023, 388(14): 1272-1283.
22
Sun D, Raynald, Huo X, et al. Sex-related differences in outcomes of endovascular treatment for anterior circulation large vessel occlusion [J]. Stroke, 2023, 54(2): 327-336.
23
Sun D, Yang X, Huo X, et al. Incidence and predictors of futile recanalisation after endovascular therapy in acute vertebrobasilar artery occlusion patients: insight from the ANGEL-ACT registry [J]. Stroke Vasc Neurol, 2023: svn-2022-002185 [pii].
24
Lin L, Zhang H, Liu F, et al. Bridging thrombolysis before endovascular therapy in stroke patients with faster core growth [J]. Neurology, 2023, 100(20): e2083-e2092.
25
Hu X, Zhou Y, Ospel J, et al. Intracranial hemorrhage in large vessel occlusion patients receiving endovascular thrombectomy with or without intravenous alteplase: a secondary analysis of the DIRECT-MT trial [J]. J Neurointerv Surg, 2023, 15(10): 977-982.
26
Huang J, Kong W, Liu C, et al. Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: a secondary analysis of a randomized clinical trial [J]. Ann Clin Transl Neurol, 2023, 10(11): 2043-2052.
27
Shang K, Zhu W, Ye L, et al. Effect of mechanical thrombectomy with and without intravenous thrombolysis on the functional outcome of patients with different degrees of thrombus perviousness [J]. Neuroradiology, 2023, 65(11): 1657-1663.
28
Guo C, Song J, Li L, et al. Association of procedure time with clinical and procedural outcome in patients with basilar occlusion undergoing embolectomy [J]. Neurology, 2023, 101(3): e253-e266.
29
Ma Y, Wang T, Wang H, et al. Extracranial-intracranial bypass and risk of stroke and death in patients with symptomatic artery occlusion: the CMOSS randomized clinical trial [J]. JAMA, 2023, 330(8): 704-714.
30
Lu M, Zhang H, Liu S, et al. Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging [J]. J Neurol Neurosurg Psychiatry, 2023, 94(7): 567-574.
31
Li JJ, Wang XP, Wang QN, et al. Long-term outcomes after conservative and EDAS treatment for 111 elderly patients with moyamoya disease: longitudinal and cross-sectional study [J]. J Neurosurg, 2023: 1-9. Online ahead of print.
32
Zhang Q, Yin Z, Zhu C, et al. Effectiveness of indirect revascularization for adult hemorrhagic moyamoya disease: a 10-year follow-up study [J]. J Neurosurg, 2023: 1-10. Online ahead of print.
33
Zhang J, Yu J, Xin C, et al. A flow self-regulating superficial temporal artery-middle cerebral artery bypass based on side-to-side anastomosis for adult patients with moyamoya disease [J]. J Neurosurg, 2023, 138(5): 1347-1356.
34
Yang X, Yu P, Zhang H, et al. Deep learning algorithm enables cerebral venous thrombosis detection with routine brain magnetic resonance imaging [J]. Stroke, 2023, 54(5): 1357-1366.
35
Tian Y, Cai X, Zhou Y, et al. Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study [J]. Stroke Vasc Neurol, 2023, 8(5): 413-423.
36
Liu ZY, Zhai FF, Liu JY, et al. Pattern of brain parenchymal damage related to cerebral small vessel disease in carriers of rare NOTCH3 variants [J]. Neurology, 2023, 101(20): e1979-e1991.
37
Tan J, Song R, Su J, et al. Establishment and multicenter external validation of a risk prediction model for de novo intracranial aneurysms based on a systematic review and meta-analysis of 19 cohorts [J]. J Neurosurg, 2023: 1-9. Online ahead of print.
38
Chen Z, Xin Y, Zou L, et al. Safety and effectiveness of stent-assisted coiling with adjunctive techniques in ruptured acute aneurysms: a propensity score-matched cohort study [J]. J Neurosurg, 2023: 1-10. Online ahead of print.
39
Han J, Tong X, Han M, et al. Flow diverters versus stent-assisted coiling in unruptured intracranial vertebral artery dissecting aneurysms [J]. J Neurosurg, 2023: 1-7. Online ahead of print.
No related articles found!
阅读次数
全文


摘要